Genmab reported DKK22.72B in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1291.97M 102.79M
AstraZeneca AZN:LN 39268M 476M
Bayer BAYN:GR € 33020M 1917M
Bluebird Bio BLUE:US $ 374.28M 496.25M
Galapagos GLPG:NA € 2643.36M 25.98M
Genmab GEN:DC DK 22719M 523M
GRIFOLS GRF:SM € 5168.17M 254.92M
Hikma Pharmaceutical HIK:LN 2.45B 163M
Immunogen IMGN:US $ 306.47M 19.12M
Lonza Group LONN:SW 9.75B 2.48B
Novartis NOVN:VX SF 67655M 10884M
William Demant Holding WDH:DC 7.98B 213M